CD4 and acute lymphoblastic leukemia: While some of our conclusions confirmed the data of other studies, which indicated the possible success of our strategy, experimental studies on the peripheral CD4+ and CD8+ T cells of pediatric patients with B-ALL should be undertaken to verify these findings.